DARPA’s Biological Technologies Office is hosting two identical Proposers Day meetings (East Coast and West Coast) to provide information to potential applicants on the structure and objectives of the new Pandemic Prevention Platform (P3) program. P3 aims to develop an integrated, end-to-end platform that uses nucleic acid sequences to halt the spread of viral infections in 60 days or less. Performers will use nucleic-acid-based technologies pioneered by DARPA as a foundation for work to overcome the remaining bottlenecks preventing rapid response to pandemic threats.
The West Coast Proposers Day will be held on March 2, 2017, from 8:00 AM – 5:00 PM EST. Participation is in person only, and advance registration is required. Please register at: http://www.cvent.com/d/9vqy52. Registration closes February 24, at 12:00 PM EST or when capacity is reached, whichever comes first.
DARPA hosts Proposers Days to provide potential performers with information on whether and how they might respond to the Government’s research and development solicitations and to increase efficiency in proposal preparation and evaluation. Therefore, the P3 Proposers Day is open only to registered potential applicants.
Additional details, including eligibility information, are available at: http://go.usa.gov/x9zgk. Full program details are available in the P3 Broad Agency Announcement: http://go.usa.gov/x9FbG.
Please address technical questions to P3@darpa.mil and refer to the P3 Special Notice number (DARPA-SN-17-20) in all correspondence.
You are now leaving the DARPA.mil website that is under the control and
management of DARPA. The appearance of hyperlinks does not constitute
endorsement by DARPA of non-U.S. Government sites or the information,
products, or services contained therein. Although DARPA may or may not
use these sites as additional distribution channels for Department of
Defense information, it does not exercise editorial control over all of
the information that you may find at these locations. Such links are
provided consistent with the stated purpose of this website.
After reading this message, click to continue